MY146795A - Process for the synthesis of organic compounds - Google Patents

Process for the synthesis of organic compounds

Info

Publication number
MY146795A
MY146795A MYPI20062506A MYPI20062506A MY146795A MY 146795 A MY146795 A MY 146795A MY PI20062506 A MYPI20062506 A MY PI20062506A MY PI20062506 A MYPI20062506 A MY PI20062506A MY 146795 A MY146795 A MY 146795A
Authority
MY
Malaysia
Prior art keywords
synthesis
organic compounds
benzenamine
imidazol
trifluoromethyl
Prior art date
Application number
MYPI20062506A
Other languages
English (en)
Inventor
Stephan Abel
Murat Acemoglu
Bernhard Erb
Christoph Krell
Joseph Sclafani
Mark Meisenbach
Mahavir Prashad
Wen-Chung Shieh
Song Xue
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37149980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY146795(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MY146795A publication Critical patent/MY146795A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MYPI20062506A 2005-06-09 2006-05-31 Process for the synthesis of organic compounds MY146795A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68897605P 2005-06-09 2005-06-09

Publications (1)

Publication Number Publication Date
MY146795A true MY146795A (en) 2012-09-28

Family

ID=37149980

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20062506A MY146795A (en) 2005-06-09 2006-05-31 Process for the synthesis of organic compounds

Country Status (25)

Country Link
US (2) US7781597B2 (enExample)
EP (3) EP2266961B1 (enExample)
JP (2) JP5225078B2 (enExample)
KR (2) KR101249199B1 (enExample)
CN (6) CN102174019B (enExample)
AR (1) AR057056A1 (enExample)
AT (1) ATE540931T1 (enExample)
AU (3) AU2006258050B2 (enExample)
BR (1) BRPI0611683A2 (enExample)
CA (4) CA2942046A1 (enExample)
DK (2) DK2266961T3 (enExample)
ES (3) ES2380489T3 (enExample)
GT (1) GT200600202AA (enExample)
HU (1) HUE028024T2 (enExample)
IN (2) IN2014DN08578A (enExample)
JO (1) JO2758B1 (enExample)
MX (1) MX2007015609A (enExample)
MY (1) MY146795A (enExample)
PE (3) PE20070109A1 (enExample)
PL (3) PL2292607T3 (enExample)
PT (3) PT1896426E (enExample)
RU (1) RU2446162C2 (enExample)
SI (2) SI2292607T1 (enExample)
TW (1) TWI380981B (enExample)
WO (1) WO2006135640A2 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1731512T1 (sl) 2004-03-05 2015-01-30 Nissan Chemical Industries, Ltd. Z izoksazolinom substituirana benzamidna spojina in sredstvo za uravnavanje škodljivih organizmov
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
MX2009013469A (es) 2007-06-13 2010-01-20 Du Pont Insecticidas de isoxazolina.
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
ES2666187T3 (es) 2007-06-27 2018-05-03 E. I. Du Pont De Nemours And Company Procedimiento de control de plagas en animales
TWI600639B (zh) 2007-08-17 2017-10-01 杜邦股份有限公司 製備５-鹵烷基-４，５-二氫異唑衍生物之化合物
WO2009045999A1 (en) 2007-10-03 2009-04-09 E. I. Du Pont De Nemours And Company Naphthalene isoxazoline compounds for control of invertebrate pests
TWI518076B (zh) 2008-04-09 2016-01-21 杜邦股份有限公司 製備雜環化合物之方法
EP2305667A3 (en) 2008-07-17 2011-05-11 Teva Pharmaceutical Industries Ltd. Nilotinib intermediates and preparation thereof
HRP20120793T1 (hr) 2008-11-05 2012-12-31 Teva Pharmaceutical Industries Ltd. Kristalni oblici nilotinib hci
WO2010060074A1 (en) * 2008-11-24 2010-05-27 Teva Pharmaceutical Industries Ltd. Preparation of nilotinib and intermediates thereof
US20110053968A1 (en) 2009-06-09 2011-03-03 Auspex Pharmaceuticals, Inc. Aminopyrimidine inhibitors of tyrosine kinase
MA34247B1 (fr) 2010-05-27 2013-05-02 Du Pont Forme cristalline du 4-[5-[3-chloro-5-(trifluorométhyl) phényl] -4,5-dihydro-5-(trifluorométhyl)-3-isoxazolyl]-n-[2-oxo-2-[(2, 2,2-trifluoroéthyl) amino] éthyl]-1-naphtalènecarboxamide
WO2013100632A1 (en) 2011-12-30 2013-07-04 Hanmi Pharm Co., Ltd. THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES
CN102592837B (zh) * 2012-03-12 2014-01-15 河北师范大学 制备超级电容器用四氯合金属季铵盐掺杂聚苯胺电极的方法
CN103694176B (zh) * 2014-01-07 2015-02-18 苏州立新制药有限公司 尼洛替尼中间体的制备方法
CN104592122B (zh) * 2014-12-09 2018-01-23 凯莱英医药集团（天津）股份有限公司 3‑(4‑甲基‑1h‑咪唑‑1‑基)‑5‑(三氟甲基)苯胺的制备方法
CN105985293B (zh) * 2015-03-04 2018-04-03 埃斯特维华义制药有限公司 尼洛替尼中间体的制备方法
EP3095782A1 (en) 2015-05-18 2016-11-23 Esteve Química, S.A. New method for preparing 3-(4-methyl-1h-imidazol-1-yl)-5-(trifluoromethyl)benzenamine
CN107201532B (zh) * 2017-05-09 2019-08-27 吉林凯莱英医药化学有限公司 芳香化合物的硝化方法
WO2019130254A1 (en) * 2018-01-01 2019-07-04 Laurus Labs Ltd An improved process for 3-(4-methyl-1h-imidazol-1-yl)-5-(trifluoromethyl) aniline
CN108530364B (zh) * 2018-04-10 2020-01-21 江苏创诺制药有限公司 一种3-(4-甲基-1h-咪唑-1-基)-5-三氟甲基苯胺单盐酸盐的晶型及其应用
CN113321647B (zh) 2018-06-15 2024-08-27 汉达癌症医药责任有限公司 激酶抑制剂的盐类及其组合物
CA3136189A1 (en) * 2019-04-06 2020-10-15 Trinapco, Inc. Sulfonyldiazoles and n-(fluorosulfonyl)azoles, and methods of making the same
EP3904342A1 (en) 2020-04-28 2021-11-03 Grindeks, A Joint Stock Company Process for the preparation of 3-(trifluoromethyl)-5-(4-methyl-1h-imidazole-1-yl)-benzeneamine hydrochloride
CN114751836B (zh) * 2021-02-23 2024-05-31 四川青木制药有限公司 3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺合成方法及其中间体
CN114853734A (zh) * 2022-06-14 2022-08-05 海南鑫开源医药科技有限公司 一种尼洛替尼游离碱的制备方法
CN116478319B (zh) * 2022-11-07 2025-07-01 华北电力大学 一种离子共价有机聚合物的制备方法及其在碱性环境吸附ReO4-的应用
CN115626880B (zh) * 2022-11-15 2023-11-14 常州大学 3-硝基-5-氰基三氟甲苯的合成方法
CN118108670B (zh) * 2023-12-28 2025-07-01 江苏希迪制药有限公司 尼罗替尼中间体3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺的精制纯化方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1051076A1 (ru) * 1982-04-09 1983-10-30 Алтайский политехнический институт Способ получени производных имидазола
PT80533B (en) * 1984-05-29 1987-04-06 Pfizer Process for preparing quinolone inotropic agents
GB8413685D0 (en) * 1984-05-29 1984-07-04 Pfizer Ltd Quinolone inotropic agents
GB8502267D0 (en) * 1985-01-30 1985-02-27 Pfizer Ltd Quinolone inotropic agents
HN2001000008A (es) * 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
GB0023383D0 (en) * 2000-09-23 2000-11-08 Synprotec Ltd 3,5-Bis (Trifluormethyl)Benzene derivatives
AR037647A1 (es) * 2002-05-29 2004-12-01 Novartis Ag Derivados de diarilurea utiles para el tratamiento de enfermedades dependientes de la cinasa de proteina
GB0215676D0 (en) 2002-07-05 2002-08-14 Novartis Ag Organic compounds
GB0222514D0 (en) 2002-09-27 2002-11-06 Novartis Ag Organic compounds
CN1939910A (zh) * 2004-12-31 2007-04-04 孙飘扬 氨基嘧啶类化合物及其盐和其制备方法与药物用途
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
GT200600207A (es) * 2005-06-09 2007-01-15 Novartis Ag Proceso para la síntesis de compuestos orgánicos

Also Published As

Publication number Publication date
CN102180836A (zh) 2011-09-14
US8008504B2 (en) 2011-08-30
WO2006135640A3 (en) 2007-08-02
PT1896426E (pt) 2012-04-12
CN101189212B (zh) 2011-05-18
CN102174021B (zh) 2013-02-27
PL2292607T3 (pl) 2014-09-30
CN102174020B (zh) 2012-11-07
HUE028024T2 (en) 2016-11-28
EP1896426A2 (en) 2008-03-12
JP2013035855A (ja) 2013-02-21
CN101189212A (zh) 2008-05-28
AU2010241374A1 (en) 2010-12-02
EP2292607B1 (en) 2014-04-09
EP1896426B1 (en) 2012-01-11
US20080200692A1 (en) 2008-08-21
KR101283109B1 (ko) 2013-07-05
CA2886482C (en) 2017-09-05
IN2014DN08578A (enExample) 2015-07-10
CA2886482A1 (en) 2006-12-21
GT200600202AA (es) 2014-06-09
DK2292607T3 (da) 2014-06-30
CN102174021A (zh) 2011-09-07
TW200716563A (en) 2007-05-01
BRPI0611683A2 (pt) 2010-09-28
CN102174020A (zh) 2011-09-07
ES2558696T3 (es) 2016-02-08
AU2006258050A1 (en) 2006-12-21
EP2266961B1 (en) 2015-10-21
SI2292607T1 (sl) 2014-09-30
CN102174019B (zh) 2013-02-13
CA2942046A1 (en) 2006-12-21
PT2292607E (pt) 2014-06-24
PE20100716A1 (es) 2010-10-25
ES2380489T3 (es) 2012-05-14
US7781597B2 (en) 2010-08-24
JP5225078B2 (ja) 2013-07-03
JP2008546645A (ja) 2008-12-25
MX2007015609A (es) 2008-02-25
JO2758B1 (en) 2014-03-15
RU2446162C2 (ru) 2012-03-27
CN102180796A (zh) 2011-09-14
PE20070109A1 (es) 2007-04-02
CA2611280A1 (en) 2006-12-21
RU2007148238A (ru) 2009-07-20
TWI380981B (zh) 2013-01-01
KR20080014010A (ko) 2008-02-13
PL2266961T3 (pl) 2016-04-29
AU2011201044A1 (en) 2011-03-31
KR20120099028A (ko) 2012-09-06
IN2014DN08588A (enExample) 2015-07-10
CN102174019A (zh) 2011-09-07
US20100280257A1 (en) 2010-11-04
PE20100715A1 (es) 2010-10-25
AR057056A1 (es) 2007-11-14
ES2465522T3 (es) 2014-06-06
CA2833394A1 (en) 2006-12-21
KR101249199B1 (ko) 2013-04-03
PL1896426T3 (pl) 2012-06-29
EP2266961A2 (en) 2010-12-29
ATE540931T1 (de) 2012-01-15
WO2006135640A2 (en) 2006-12-21
CN102180836B (zh) 2012-11-21
EP2292607A2 (en) 2011-03-09
AU2010241374B2 (en) 2011-11-03
CA2611280C (en) 2014-01-28
ES2380489T8 (es) 2012-06-22
EP2266961A3 (en) 2011-07-27
EP2292607A3 (en) 2011-04-27
PT2266961E (pt) 2016-02-05
AU2006258050B2 (en) 2010-12-09
CA2833394C (en) 2016-03-29
DK2266961T3 (en) 2016-01-25
SI2266961T1 (sl) 2016-02-29

Similar Documents

Publication Publication Date Title
TW200716563A (en) Process for the synthesis of organic compounds
TW200800997A (en) Chemical compounds
MA31574B1 (fr) Dérivés de pyrazole et leur utilisation comme inhibiteurs de raf
WO2007085895A3 (en) Fap inhibitors
MY162022A (en) Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
MX2009002274A (es) Compuestos de enlace fxr heterociclicos.
JO2732B1 (en) Organic compounds
WO2009121033A3 (en) Substituted nitrogen heterocycles and synthesis and uses thereof
MX2010004669A (es) Proceso para la preparacion de derivados de isoindol asi como tambien un proceso para la preparacion de sus intermediarios.
MX2010002938A (es) Derivados de (3-hidroxi-4-amino-butan-2-il)-3-(2-tiazol-2-il-pirro lidin-1-carbonil)benzamida y compuestos relacionados como inhibidores de beta-secretasa para tratar enfermedad de alzheimer.
NZ593172A (en) 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
GEP20125512B (en) Process for synthesis of agomelatin
MX2010005528A (es) 5-[(3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino]-1h-quinolin-2-o nas, un proceso para su produccion y su uso como agentes antiinflamatorios.
WO2008053334A3 (en) An improved process for preparing rosuvastatin calcium
TW200710084A (en) Process for the synthesis of organic compounds
TW200738621A (en) Chemical process
TW200728310A (en) Process for the preparation of ferri-succinylcasein
PT1723140E (pt) Processo para a preparação de inibidores de triptase
TW200745106A (en) Chemical compounds
MX2007007446A (es) Procesos para la produccion de 4-aminoquinazolinas.
NZ599218A (en) Process for the manufacture of organic compounds
UA93860C2 (ru) Способ получения пиразолов, способ региоселективного алкилирования и применение фосфата или фосфоната b способе
MX2009013336A (es) Sintesis de 3-aminopirazoles sustituidos.
TW200801011A (en) New compounds II
TW200630369A (en) Process for preparing purine compounds